NCT03116893View on ClinicalTrials.gov

Drug-drug Interaction (DDI) With a P-gp Inhibitor, Organic Anion Transporting Polypeptide OATP-inhibitor, Food Effect

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 19, 2017

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Healthy
Interventions
DRUG

BI 685509 After Standardised Breakfast

High-fat high calorie breakfast

DRUG

Itraconazole

Administration of itraconazole together with BI 685509

DRUG

Rifampin

Administration of rifampicin together with BI 685509

DRUG

BI 685509 Fasted Conditions

BI 685509, given alone

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03116893 - Drug-drug Interaction (DDI) With a P-gp Inhibitor, Organic Anion Transporting Polypeptide OATP-inhibitor, Food Effect | Biotech Hunter | Biotech Hunter